BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12119154)

  • 1. Applications of hormesis in toxicology, risk assessment and chemotherapeutics.
    Calabrese EJ; Baldwin LA
    Trends Pharmacol Sci; 2002 Jul; 23(7):331-7. PubMed ID: 12119154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences.
    Calabrese EJ
    Environ Pollut; 2005 Dec; 138(3):379-411. PubMed ID: 16098930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormesis is central to toxicology, pharmacology and risk assessment.
    Calabrese EJ
    Hum Exp Toxicol; 2010 Apr; 29(4):249-61. PubMed ID: 20332169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Historical blunders: how toxicology got the dose-response relationship half right.
    Calabrese EJ
    Cell Mol Biol (Noisy-le-grand); 2005 Dec; 51(7):643-54. PubMed ID: 16359616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormesis: U-shaped dose responses and their centrality in toxicology.
    Calabrese EJ; Baldwin LA
    Trends Pharmacol Sci; 2001 Jun; 22(6):285-91. PubMed ID: 11395156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormesis: changing view of the dose-response, a personal account of the history and current status.
    Calabrese EJ
    Mutat Res; 2002 Jul; 511(3):181-9. PubMed ID: 12088716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicological awakenings: the rebirth of hormesis as a central pillar of toxicology.
    Calabrese EJ
    Toxicol Appl Pharmacol; 2005 Apr; 204(1):1-8. PubMed ID: 15781288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inference for the existence of hormetic dose-response relationships in toxicology studies.
    Kim SB; Bartell SM; Gillen DL
    Biostatistics; 2016 Jul; 17(3):523-36. PubMed ID: 26873961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology rewrites its history and rethinks its future: giving equal focus to both harmful and beneficial effects.
    Calabrese EJ
    Environ Toxicol Chem; 2011 Dec; 30(12):2658-73. PubMed ID: 21932295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormesis: why it is important to toxicology and toxicologists.
    Calabrese EJ
    Environ Toxicol Chem; 2008 Jul; 27(7):1451-74. PubMed ID: 18275256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormesis: how it could affect the risk assessment process.
    Calabrese EJ; Cook RR
    Hum Exp Toxicol; 2005 May; 24(5):265-70. PubMed ID: 16004191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities between the Yin/Yang Doctrine and Hormesis in Toxicology and Pharmacology.
    Sun H; Calabrese EJ; Lin Z; Lian B; Zhang X
    Trends Pharmacol Sci; 2020 Aug; 41(8):544-556. PubMed ID: 32564900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormesis: from marginalization to mainstream: a case for hormesis as the default dose-response model in risk assessment.
    Calabrese EJ
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):125-36. PubMed ID: 15163548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormesis: implications for public policy regarding toxicants.
    Lave LB
    Annu Rev Public Health; 2001; 22():63-7. PubMed ID: 11274511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormesis: improving predictions in the low-dose zone.
    Calabrese EJ
    Exp Suppl; 2012; 101():551-64. PubMed ID: 22945582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potential role of hormesis in risk assessment in occupational toxicology].
    Iavicoli I; Carelli G
    G Ital Med Lav Ergon; 2003; 25 Suppl(3):174-5. PubMed ID: 14979136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormesis outperforms threshold model in National Cancer Institute antitumor drug screening database.
    Calabrese EJ; Staudenmayer JW; Stanek EJ; Hoffmann GR
    Toxicol Sci; 2006 Dec; 94(2):368-78. PubMed ID: 16950854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormesis: Toxicological foundations and role in aging research.
    Calabrese EJ
    Exp Gerontol; 2013 Jan; 48(1):99-102. PubMed ID: 22525590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critique of the use of hormesis in risk assessment.
    Kitchin KT; Drane JW
    Hum Exp Toxicol; 2005 May; 24(5):249-53. PubMed ID: 16004188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Getting the dose-response wrong: why hormesis became marginalized and the threshold model accepted.
    Calabrese EJ
    Arch Toxicol; 2009 Mar; 83(3):227-47. PubMed ID: 19234688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.